The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2022 | Immune reconstitution and vaccination in multiple myeloma
Mattia D’Agostino, MD, University of Turin, European Myeloma Network, Turin, Italy, shares the key topics that were discussed at the session on immune reconstitution and vaccination in multiple myeloma that was held at this year’s IMS meeting. In this session, experts discussed anti-infectious and anti-tumor immunity and predictors of response to COVID-19 and other anti-infectious vaccines. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
